Schizophrenia causes measurable changes to brain structure, chemistry, and connectivity that begin before symptoms ever appear. These changes affect how the brain processes information, communicates between regions, and maintains healthy tissue over time. Understanding what’s happening inside the brain helps explain why schizophrenia produces such a wide range of symptoms, from hallucinations and disordered thinking to memory problems and emotional withdrawal.
Gray Matter Loss and Enlarged Ventricles
The most visible structural change in schizophrenia is a reduction in gray matter, the outer layer of brain tissue where most of the brain’s processing happens. Brain imaging studies comparing people with schizophrenia to healthy controls consistently find less gray matter in several key regions. One particularly telling finding comes from studies of people who have never taken antipsychotic medication: even in these untreated individuals, the right superior temporal gyrus, a region involved in processing language and sound, shows significantly reduced volume. This rules out medication as the sole explanation for the tissue loss.
The brain’s fluid-filled cavities, called ventricles, also expand in schizophrenia. A meta-analysis of longitudinal brain scans found that ventricular enlargement progresses over time at a rate significantly greater than normal aging, with an effect size of 0.45. This progressive expansion continues even in people who have been living with the illness for years, suggesting ongoing tissue changes rather than a one-time event. Larger ventricles reflect surrounding brain tissue shrinking or failing to develop fully.
A Chemical Imbalance in Two Directions
Schizophrenia doesn’t involve a single chemical going wrong. It involves at least two major signaling systems pulling in different directions across different parts of the brain.
The first is dopamine. In deep brain pathways connecting to emotional and reward centers, dopamine activity runs too high. This overactivity is closely linked to positive symptoms: hallucinations, delusions, and disorganized thinking. At the same time, dopamine activity in pathways reaching the prefrontal cortex (the brain’s planning and reasoning center) runs too low. That underactivity contributes to negative symptoms like flat emotional expression, social withdrawal, and difficulty with abstract thinking. This two-directional problem explains why treating one set of symptoms can sometimes worsen the other.
The second system involves glutamate, the brain’s primary excitatory chemical messenger. Receptors that respond to glutamate appear to function poorly in schizophrenia. When these receptors don’t activate properly, a chain reaction unfolds: inhibitory neurons that normally keep brain activity in check downregulate themselves, leading to runaway excitatory signaling that can damage neurons over time. Drugs that block these same receptors in healthy people, like ketamine and PCP, produce symptoms strikingly similar to schizophrenia, including hallucinations, paranoia, and cognitive problems. Depending on how severe and prolonged this receptor dysfunction becomes, it can drive the kind of structural brain changes visible on imaging scans.
Synaptic Pruning Gone Wrong
During adolescence, every brain undergoes a normal process of trimming unused neural connections to make remaining circuits more efficient. In schizophrenia, this pruning process appears to be overly aggressive, particularly in the prefrontal cortex. A growing body of evidence, including studies showing that immune cells called microglia strip away synapses more aggressively in people with schizophrenia, supports this model.
The current theory is that a vulnerability in prefrontal brain circuits is established early in development but stays hidden through childhood. When adolescent pruning kicks in, it pushes these already-fragile circuits past a tipping point by removing too many excitatory connections. The result is disrupted synchronized neural activity in the prefrontal cortex, which is essential for working memory, planning, and organized thought. This explains why schizophrenia typically emerges in late adolescence or early adulthood, even though the underlying vulnerability was present much earlier. The excessive prefrontal pruning also triggers a downstream effect: increased dopamine activity in deeper brain structures, connecting the developmental story directly to the chemical imbalance described above.
Disrupted Communication Between Brain Networks
A healthy brain maintains a careful balance between two major networks. One, called the default mode network, is active during internal thought, daydreaming, and self-reflection. The other, the task-positive network, activates when you focus on something in the outside world. Normally, when one network ramps up, the other quiets down. In schizophrenia, this seesaw relationship breaks down.
Studies using functional brain imaging show that people with schizophrenia often have reduced separation between these two networks, meaning internal and external processing bleed into each other rather than alternating cleanly. This blurring may help explain why people with schizophrenia sometimes struggle to distinguish internal experiences from external reality. Connectivity patterns also correlate with specific symptoms. Stronger-than-normal connections between certain posterior brain regions and areas involved in auditory processing are associated with hallucinations, while weaker connectivity in frontal regions tracks with negative symptoms like emotional flatness and reduced motivation.
What Happens During Hallucinations
Auditory hallucinations, the experience of hearing voices that aren’t there, are one of the most recognizable symptoms of schizophrenia. For years, researchers assumed these hallucinations would activate the brain’s auditory processing centers, essentially tricking the brain into “hearing” sound. A study published in Scientific Reports challenged this assumption directly. Using brain imaging during moments when participants reported hearing voices, researchers found that the primary auditory cortex (Heschl’s gyrus) barely activated above baseline during hallucinations, even though it responded robustly to actual speech played through headphones.
Instead, hallucinations activated language production and verbal memory regions, including Broca’s area (involved in generating speech) and Wernicke’s area (involved in comprehending it), along with their counterparts on the right side of the brain. The precentral gyrus and supplementary motor area, both involved in planning and executing speech movements, also lit up. This suggests that auditory hallucinations are generated by the brain’s own language machinery rather than by a false perceptual signal mimicking real sound. The voices people hear may be closer to inner speech that the brain fails to recognize as self-generated.
Memory and the Hippocampus
People with schizophrenia commonly experience problems with memory, particularly the ability to recall information after a delay. These deficits have a clear structural basis. The hippocampus, the brain’s central hub for forming and retrieving memories, is consistently smaller in people with schizophrenia compared to healthy controls, with the left hippocampus especially affected.
Recent research has drilled down into specific subregions of the hippocampus. A study comparing 57 people with schizophrenia to 32 matched controls found that volume reductions in a subregion called CA1 on the left side were directly correlated with poorer recall performance. People with smaller CA1 volumes performed worse on both immediate and delayed free recall tasks. Notably, this relationship only held for participants with schizophrenia, not for healthy controls, suggesting that schizophrenia makes the hippocampus more vulnerable to the functional consequences of volume loss. Reduced neuropil, the dense web of connections between neurons, has been observed in the hippocampus as well as the prefrontal cortex and thalamus, pointing to a loss of the microscopic wiring that supports learning and memory.
The Brain Ages Faster
One way researchers now quantify the overall impact of schizophrenia on the brain is by estimating “brain age,” a measure of how old the brain looks on a scan compared to the person’s actual age. In early-illness schizophrenia, the brain appears roughly 0.6 to 1 year older than expected compared to healthy peers. That gap may sound small, but it’s present early in the disease course and is statistically significant. People at clinical high risk for psychosis who later convert to a psychotic disorder also show a greater brain age gap (about 0.9 years) compared to high-risk individuals who don’t convert, suggesting this accelerated aging may be a marker of disease progression rather than just a consequence of long-term illness.
Do Medications Change the Brain Too?
This is a question that complicates nearly every study of schizophrenia’s effects on the brain. In a landmark experiment, macaque monkeys given chronic antipsychotic exposure showed an 8 to 11 percent reduction in overall brain weight, affecting both gray and white matter. In human studies, greater intensity of antipsychotic treatment has been associated with progressive reductions in brain tissue volume over time. At the same time, some brain regions, particularly structures deep in the brain called the basal ganglia, actually increase in volume with treatment. These increases appear to be directly related to how the medications work and may also be connected to some of their side effects, like movement problems.
This doesn’t mean the brain changes seen in schizophrenia are caused by medication. Studies of people who have never taken antipsychotics still show gray matter reductions and ventricular enlargement. But it does mean that some portion of the structural changes observed in long-term studies reflect a combination of the disease itself and the effects of treatment, and disentangling the two remains one of the field’s ongoing challenges.